Juvena Therapeutics, inc.
Juvena Therapeutics is a biotech company accelerating the development of regenerative therapeutics by unlocking the therapeutic potential of secreted proteins. Secreted proteins are a class of biologics with proven therapeutic potential that has been under-leveraged due to the complexity of identifying and screening such proteins. The company is developing a patent-pending computational drug discovery and development platform that is delivering novel biologics to address major unmet medical needs in chronic and age-related diseases by mining regenerative proteins secreted by diverse types of human stem cells. Juvena has generated hits and new drug targets across several therapeutic areas.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Pharmaceuticals
- Market Focus:
- Nationally (across the country)
About Us
Mapping Secreted Proteins to Unmet Medical Needs
Our mission is to unlock the therapeutic potential of secreted proteins and to engineer them into life-saving therapeutics
- Juvena Therapeutics is a venture-backed biotechnology company unlocking the therapeutic potential of stem cell-secreted proteins and accelerating their development into life-saving therapeutics for chronic and age-related diseases.
- We are achieving this through an Artificial Intelligence-enabled platform that combines a compounding database mapping secreted proteins to specific disease phenotypes, an in silico screening technology, wetlab screening in primary human cell and animal models, and protein engineering capabilities.
- Our goal is to use this integrated platform to accelerate the development of regenerative biologics.
Pipeline
Juvena’s platform is applicable across a wide scope of disease indications. Juvena has focused initially on mapping secreted proteins to neuromuscular and skeletal diseases, and are exploring additional areas including cardio-metabolic, pulmonary, and inflammatory. We’re excited to explore partnerships with biopharma companies looking to benefit from the mapping of secreted proteins to therapeutic focus areas.
